Last reviewed · How we verify

NCT02299947: FIBTEG

Bloodtranfusions After Aortic Surgery

Terminated Phase 4 Last updated 10 May 2019
What this trial tests

Phase 4 trial testing Haemocomplettan P in Hemorrhage in 27 participants. Terminated before completion.

Timeline
1 August 2014
Primary endpoint
26 April 2018
26 April 2018

Quick facts

Lead sponsorSt. Antonius Hospital
PhasePhase 4
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment27
Start date1 August 2014
Primary completion26 April 2018
Estimated completion26 April 2018
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

St. Antonius Hospital

Who can join

18 and older, any sex, with Hemorrhage or Thoracic Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to answer the following question: Leads a primary coagulation corrected with a single dose of fibrinogen concentrate after ascending aorta-arc reconstruction to a decrease in the number of allogenic blood transfusions, compared to placebo?

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
    Fabes J, Brunskill SJ, Curry N, Doree C, et al · · 2018 · cited 11× · PMID 30582172 · DOI 10.1002/14651858.cd010649.pub2
  2. Does Intraoperative Fibrinogen Affect Blood Loss or Transfusion Practice After Aortic Arch Surgery: A Prematurely Ended Randomized Trial.
    Vlot EA, Hackeng CM, Aper SJA, Sonker U, et al · · 2022 · cited 1× · PMID 36476152 · DOI 10.1177/10760296221144042

Verify or expand the search:

Other recruiting trials for Hemorrhage

Currently open trials in the same condition.

Other St. Antonius Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02299947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing